Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy
ERAS
Comparison of ERAS (Early Recovery After Surgery) Protocol With Conventional Protocol After Laparoscopic Gastrectomy: A Prospective Randomized Controlled Trial (Phase II Study))
1 other identifier
interventional
100
1 country
1
Brief Summary
Enhanced Recovery After Surgery (ERAS) programs have been introduced with purposes of reducing the surgical stress response and obtaining optimal recovery after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 gastric-cancer
Started Aug 2012
Typical duration for phase_2 gastric-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2012
CompletedStudy Start
First participant enrolled
August 1, 2012
CompletedFirst Posted
Study publicly available on registry
September 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedJanuary 5, 2017
January 1, 2017
2 years
July 15, 2012
January 4, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recovering Rate
1. Tolerance of diet for 24 hours A. Able to eat one third of more of soft-blend meal without abdominal discomfort, bloating, nausea, or vomiting 2. Analgesic-free (oral or IV analgesic drugs not necessary after cessation of PCA) 3. Safe ambulation (ambulation of 600m without assistance) 4. Afebrile status without major complications (fever defined as body temperature greater than 37.5) * Above total 4 criteria should be satisfied for the evaluation of complete recovery.
4 days after surgery
Secondary Outcomes (7)
Postoperative length of hospital stay
up to 4 weeks after surgery
Time to tolerance of a full diet
up to 1 month after surgery
Time to first bowel motion Time to first bowel motion
up to 7 days after surgery
Complications during the admissionTime to first bowel motion
up to 30 days after surgery
Readmission rate
up to 30 days after surgery
- +2 more secondary outcomes
Study Arms (2)
ERAS perioperative cares
ACTIVE COMPARATORPatients planned to undergoing laparoscopic gastrectomy, following the ERAS protocols.
Conventional perioperative cares
ACTIVE COMPARATORPatents will be managed by our hospital's critical pathways.
Interventions
1. Patient's preoperative counseling \& education before surgery 2. No Bowel preparation 3. Oral Carbohydrate Solution (OCS) loading until 2hours before surgery 4. Fluid restriction \& Management by pulse contour analysis or transesophageal doppler 5. Early mobilization 6. Early oral feeding (postoperative 1 day - sips of water, 2 days - semifluid diet (SFD), 3 days - soft blended diet (SBD)) 7. Epidural patient controlled analgesics (no opioids analgesics) 8. Postoperative Nausea Active Control 9. Thromboembolism prophylaxis by low molecular weighted heparin (LMWH) 10. Perioperative High content Oxygen therapy 11. No drain insertion 12. No Levin tube 13. Patients will be discharged at POD#4 if there's no problem.
1. No Patient's preoperative counseling \& education before surgery 2. Bowel preparation 3. No Oral Carbohydrate Solution (OCS) loading until 2hours before surgery 4. Conventional Fluid Management by clinical signs (Urine output, heart rate etc.) 5. Conventional Mobilization 6. Conventional oral feeding (POD#2 SOW, #3 SFD, #4 SBD) 7. IV PCA 8. Postoperative Nausea Control if needed 9. No Thromboembolism prophylaxis 10. No or Low Content Oxygen therapy 11. Routine drain insertion 12. Levin tube insertion if needed
Eligibility Criteria
You may qualify if:
- Elective surgery
- American Society of Anesthesiologists (ASA) scores \< 3
- \< Age \< 80
- Gastric cancer, adenocarcinoma, possible to perform laparoscopic distal gastrectomy
- Informed consent
- No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric cancer or other type of cancer.
- No systemic inflammatory disease
You may not qualify if:
- Emergency operation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Bundang Hospital
Seongnam, Geynggi, South Korea
Related Publications (1)
Kang SH, Lee Y, Min SH, Park YS, Ahn SH, Park DJ, Kim HH. Multimodal Enhanced Recovery After Surgery (ERAS) Program is the Optimal Perioperative Care in Patients Undergoing Totally Laparoscopic Distal Gastrectomy for Gastric Cancer: A Prospective, Randomized, Clinical Trial. Ann Surg Oncol. 2018 Oct;25(11):3231-3238. doi: 10.1245/s10434-018-6625-0. Epub 2018 Jul 26.
PMID: 30051365DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hyung-Ho Kim, M.D., Ph.D.
Department of Surgery, SNUBH
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 15, 2012
First Posted
September 10, 2013
Study Start
August 1, 2012
Primary Completion
August 1, 2014
Study Completion
April 1, 2016
Last Updated
January 5, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share